Northwell Health: COVID-19 trials

The registry lists 13 COVID-19 studies with Northwell Health as lead sponsor. 0 are open to participants now and 3 have results posted.

Phase 1 1Phase 2 1Phase 3 3No phase 8(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Randomized Open Investigation Determining Steroid DoseCompletedNCT04834375Phase 3Results posted
• Famotidine vs Placebo for the Treatment of Non-Hospitalized Adults With COVID-19CompletedNCT04724720Phase 2Results posted
• Full Dose Heparin Vs. Prophylactic Or Intermediate Dose Heparin in High Risk COVID-19 PatientsCompletedNCT04401293Phase 3Results posted
• Transplantation of Deceased Donors With COVID-19 Into COVID-19 Negative Recipients Utilizing Casirivimab and Imdevimab Antibody CocktailWithdrawnNCT05157997Phase 1
• Parental Perception of COVID-19 Vaccine in Technology Dependent PatientsCompletedNCT05084976
• P-Co-Li (Pulmonary Covid-19 Study)WithdrawnNCT04782700Not applicable
• Associations Between COVID-19 ARDS Treatment, Clinical Trajectories and Liberation From Mechanical Ventilator - an Analysis of the NorthCARDS DatasetCompletedNCT04729075
• Mild Hypothermia for COVID-19 ARDSWithdrawnNCT04570462Not applicable
• Workforce Serosurveillance to Track Long-term Modifications to COVID-19 Exposure Due to Factors in the Built EnvironmentCompletedNCT04542200
• Ambulatory Management of Moderate to High Risk COVID-19 (SARS-CoV-2) Patients - The Coronavirus Related Outpatient Work Navigators (CROWN) ProtocolCompletedNCT04476602
• Incidence of COVID-19 Test Conversion in Post-surgical PatientsCompletedNCT04392323Not applicable
• Famotidine Outpatient COVID-19 Treatment StudyCompletedNCT04389567
• Multi-site Adaptive Trials for COVID-19CompletedNCT04370262Phase 3